A genome-wide screen for susceptibility loci in ankylosing spondylitis

Arthritis and Rheumatism

Volumn 41, Issue 4, 1998, Pages 588-595

  Brown, Matthew A ^a   Pile, Kevin D ^b   Kennedy, L Gail ^c   Campbell, Duncan ^d   Andrew, Lee ^a   March, Ruth ^d   Shatford, Jane L ^a   Weeks, Daniel E ^a,e   Calin, Andrei ^b   Wordsworth, B Paul ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b QUEEN ELIZABETH HOSPITAL   (Australia)

^c ROYAL NATIONAL HOSPITAL FOR RHEUMATIC DISEASES   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B ANTIGEN; HLA DR ANTIGEN;

ANKYLOSING SPONDYLITIS; ARTICLE; DATA ANALYSIS; FAMILY HISTORY; GENE LOCATION; GENE LOCUS; GENETIC LINKAGE; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; HLA MATCHING; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MARKER GENE; MEDICAL RECORD; PRIORITY JOURNAL; RISK ASSESSMENT; UNITED KINGDOM;

CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 4; FAMILY HEALTH; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOME, HUMAN; HUMANS; INFLAMMATORY BOWEL DISEASES; LINKAGE (GENETICS); LOD SCORE; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; PSORIASIS; SPONDYLITIS, ANKYLOSING;

EID: 0031946030     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199804)41:4<588::AID-ART5>3.0.CO;2-0     Document Type: Article

References (37)

1. Calin A, Marder A, Becks E, Burns T. Genetic differences between B27 positive patients with ankylosing spondylitis and B27 positive healthy controls. Arthritis Rheum 1983;26:1460-4.
2. Van der Linden SM, Valkenburg HA, de Jongh BM, Cats A. The risk of developing ankylosing spondylitis in HLA-B27 positive individuals: a comparison of relatives of spondylitis patients with the general population. Arthritis Rheum 1984;27:241-9.
3. Brown MA, Kennedy LG, MacGregor AJ, Darke C, Duncan E, Shatford JL, et al. Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. Arthritis Rheum 1997;40:1823-8.
4. Taurog JD, Satumtira N, Richardson JA, Simmons WA, Hammer RE. Alleles of the inbred dark Agouti rat strain are protective against inflammatory disease in HLA-B27 transgenic rats [abstract]. Arthritis Rheum 1996;39 Suppl 9:S121.
5. Rubin LA, Amos CI, Wade JA, Martin JR, Bale SJ, Little AH, et al. Investigating the genetic basis for ankylosing spondylitis: linkage studies with the major histocompatibility complex region. Arthritis Rheum 1994;37:1212-20.
6. Brown MA, Pile KD, Gibson K, Kennedy LG, Calin A, Farrall M, et al. The HLA component of the genetic contribution to ankylosing spondylitis [abstract]. Br J Rheumatol 1995;34 Suppl 1:76.
7. Risch N. Linkage strategies for genetically complex traits. I. Multilocus models. Am J Hum Genet 1990;46:222-8.
8. Lawrence J. Rheumatism in populations. London: William Heinemann Medical Books; 1977. p. 282-324.
9. Van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum 1984; 27:361-8.
10. Brown MA, Pile KD, Kennedy LG, Calin A, Darke C, Bell J, et al. HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom. Ann Rheum Dis 1996;55:268-70.
11. Wordsworth BP, Allsopp CE, Young RP, Bell JI. HLA-DR typing using DNA amplification by the polymerase chain reaction and sequential hybridization to sequence-specific oligonucleotide probes. Immunogenetics 1990;32:413-8.
12. Reed PW, Davies JL, Copeman JB, Bennett ST, Palmer SM, Pritchard LE, et al. Chromosome-specific microsatellite sets for fluorescence-based, semi-automated genome mapping. Nat Genet 1994;7:390-5.
13. Hsieh S-L, March RE, Khanna A, Cross SJ, Campbell RD. Mapping of 10 novel microsatellites in the MHC class III region: application to the study of autoimmune disease. J Rheumatol 1997;24:220-2.
14. Satsangi J, Parkes M, Louis E, Hashimoto E, Kato N, Welsh K, et al. Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosome 3, 7, and 12. Nat Genet 1996;14:199-202.
15. Falk C, Rubinstein P. Haplotype relative risks: an easy reliable way to construct a proper control sample for risk calculations. Ann Hum Genet 1987;51:227-33.
16. Kruglyak E, Daly MJ, Reeve Daly MP, Lander ES. Parametric and nonparametric linkage analysis: a unified multipoint approach. Am J Hum Genet 1996;58:1347-63.
17. Risch N. Assessing the role of HLA-linked and unlinked determinants of disease. Am J Hum Genet 1987;40:1-14.
18. Cordell H, Olson J. Confidence interval calculation from relative risk estimates. Genet Epidemiol. In press.
19. De Blécourt J, Polman A, de Blécourt-Meindersma T. Hereditary factors in rheumatoid arthritis and ankylosing spondylitis. Ann Rheum Dis 1961;20:215-23.
20. Wordsworth P. Genes and arthritis. Br Med Bull 1995;51:249-66.
21. Woodrow JC, Nichol FE, Whitehouse GH. Genetic studies in ankylosing spondylitis. Br J Rheumatol 1983;22 Suppl 2:12-7.
22. Spielman RS, Ewens WJ. The TDT and other family-based tests for linkage disequilibrium and association. Am J Hum Genet 1996;59:983-9.
23. Nair R, Henseler T, Jenisch S, Stuart P, Bichakjian C, Lenk W, et al. Evidence for two psoriasis susceptibility loci (HLA and 17q) and two novel candidate regions (16q and 20p) by genome-wide scan. Hum Mol Genet 1997;6:1349-56.
24. Tomfohrde J, Silverman A, Barnes R, Fernandez Vina MA, Young M, Lory D, et al. Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q. Science 1994;264:1141-5.
25. Matthews D, Fry L, Powles A, Weber J, McCarthy M, Fisher E, et al. Evidence that a locus for familial psoriasis maps to chromosome 4q. Nat Genet 1996;14:231-3.
26. Suarez AM, Russell AS. B27 homozygosity and ankylosing spondylitis. J Rheumatol 1987;14:302-4.
27. Lochead JA, Chalmers IM, Marshall WH, Larsen B, Skanes VM, Payne RH, et al. HLA-B27 haplotypes in family studies of ankylosing spondylitis. Arthritis Rheum 1983;26:1011-6.
28. Khan MA, Kushner I, Braun WE, Zachary AA, Steinberg AG. HLA-B27 homozygosity in ankylosing spondylitis: relationship to risk and severity. Tissue Antigens 1978;11:434-8.
29. Reveille JD, Suarez-Almazor ME, Russell AS, Go RC, Appleyard J, Barger BO, et al. HLA in ankylosing spondylitis: is HLA-B27 the only MHC gene involved in disease pathogenesis? Semin Arthritis Rheum 1994;23:295-309.
30. De Jongh BM, van der Linden SM, Volkers WS, Cats A. Genetics of non-HLA marker genes in HLA-B27-positive and -negative ankylosing spondylitis families. Scand J Rheumatol Suppl 1990;87: 127-30.
31. Brown MA, Wordsworth BP. Predisposing factors to spondyloarthropathies. Curr Opin Rheumatol 1997;9:308-14.
32. Beyeler C, Armstrong M, Bird HA, Idle JR, Daly AK. Relationship between genotype for the cytochrome P450 CYP2D6 and susceptibility to ankylosing spondylitis and rheumatoid arthritis. Ann Rheum Dis 1996;55:66-8.
33. Mielants H, Veys EM, Cuvelier C, de Vos M. Ileocolonoscopic findings in seronegative spondylarthropathies. Br J Rheumatol 1988;2:95-105.
34. Rudolph U, Finegold MJ, Rich SS, Harriman GR, Srinivasan Y, Brabet P, et al. Ulcerative colitis and adenocarcinoma of the colon in G alpha i2-deficient mice. Nat Genet 1995;10:143-50.
35. Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 1995;11:241-7.
36. Hauser ER, Boehnke M, Guo SW, Risch N. Affected-sib-pair interval mapping and exclusion for complex genetic traits: sampling considerations. Genet Epidemiol 1996;13:117-37.
37. Terwilliger J, Shannon W, Lathrop G, Nolan J, Goldin L, Chase G, et al. True and false positive peaks in genomewide scans: applications of length-based sampling to linkage mapping. Am J Hum Genet 1997;61:430-8.